Clinical Trial Update: Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety and pharmacokinetics of carfilzomib in relapsed/refractory multiple myeloma across varying renal function; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)

Snippet

Sponsor: Amgen | Conditions: Multiple Myeloma, Renal Insufficiency | Phase 2 | Status: COMPLETED | Results posted: 2015-12-09